Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Microbiology Spectrum|January 9, 2023
Risk Factors for Carbapenem-Resistant <i>Enterobacterales</i> Clinical Treatment FailureNicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomesAshlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Microbiology Spectrum|November 29, 2023
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2023
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomesAmer El Ghali, Taylor Morrisette, Sara Alosaimy, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centersAshlan J Kunz Coyne, Chloe Judd, Kristen Lucas, et al.
Pageof 2